SK Chemical/Pharm announce Korean launch of frovatripan.

Published: 2004-10-08 06:35:00

Updated: 2004-10-08 06:35:00

SK Chemical and SK Pharm said on October 3 that they signed an exclusive agreement with UK-based Vernalis Co. for the distribution of anti-migraine drug Migard (frovatriptan succinate) in Korea, noting that the launching of frovatriptan in domestic market will be a significant step towards their objective of strengthening the CNS sector, together with a leading blood circulation enhancer Ginexi...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.